In ₹ Crore except Per Share Latest Annual | BLUEJET FY25 | DIVISLAB FY26 | AARTIPHARM FY26 | CAPLIPOINT FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | — | 96.58× | 42.98× | ◆ 32.63× | 42.98× | |
| P/B | — | 14.77× | ◆ 3.53× | 5.76× | 5.76× | |
| EV/EBITDA | — | 71.92× | ◆ 22.17× | 26.87× | 26.87× | |
| Market Cap | — | ₹2.48L Cr | ₹7,509 Cr | ₹20,920 Cr | ₹20,920 Cr | |
| Growth | ||||||
| Revenue CAGR 3Y | — | 10.78% | -2.20% | ◆ 14.25% | 10.78% | |
| Revenue CAGR 5Y | — | 8.67% | — | ◆ 15.56% | 12.12% | |
| Net Income CAGR 3Y | — | 12.09% | -3.35% | ◆ 19.89% | 12.09% | |
| Revenue YoY (latest Q) | — | 27.80% | ◆ 38.74% | 19.63% | 27.80% | |
| Net Income YoY (latest Q) | — | ◆ 65.50% | 53.82% | 18.79% | 53.82% | |
| Profitability | ||||||
| EBITDA Margin | — | 32.59% | 20.29% | ◆ 34.79% | 32.59% | |
| Net Income Margin | — | 24.32% | 9.60% | ◆ 29.71% | 24.32% | |
| Return on Common Equity | — | 15.32% | 8.13% | ◆ 17.66% | 15.32% | |
| Return on Capital Employed | — | 16.55% | 10.41% | ◆ 18.80% | 16.55% | |
| Return on Assets | — | 12.82% | 5.02% | ◆ 16.06% | 12.82% | |
| Credit & Quality | ||||||
| Total Debt/Equity | — | ◆ 0.00× | 0.32× | 0.00× | 0.00× | |
| Interest Coverage | — | 129.48× | 5.65× | ◆ 790.90× | 129.48× | |
| Scale — latest FY | ||||||
| Revenue / Total Income | — | ₹10,560 Cr | ₹1,819 Cr | ₹2,187 Cr | ₹2,187 Cr | |
| Net Income | — | ₹2,568 Cr | ₹175 Cr | ₹650 Cr | ₹650 Cr | |
| Total Assets | ₹1,418 Cr | ₹20,033 Cr | ₹3,482 Cr | ₹4,045 Cr | ₹4,045 Cr -65% | |
| EPS | — | ₹96.75 | ₹19.27 | ₹84.36 | ₹84.36 | |
| Book Value per Share | — | ₹632.49 | ₹234.35 | ₹477.74 | ₹477.74 | |